Thrivent Financial for Lutherans Sells 622 Shares of The Clorox Company (NYSE:CLX)

Thrivent Financial for Lutherans cut its holdings in The Clorox Company (NYSE:CLX) by 6.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,469 shares of the company’s stock after selling 622 shares during the period. Thrivent Financial for Lutherans’ holdings in Clorox were worth $1,375,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. Brooklyn Investment Group lifted its stake in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after acquiring an additional 95 shares during the last quarter. Continuum Advisory LLC increased its stake in Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the period. Asset Planning Inc bought a new stake in Clorox in the fourth quarter valued at approximately $32,000. Halbert Hargrove Global Advisors LLC purchased a new stake in shares of Clorox during the fourth quarter valued at approximately $36,000. Finally, BankPlus Trust Department bought a new position in shares of Clorox in the fourth quarter worth approximately $40,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Price Performance

CLX stock opened at $146.18 on Monday. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The firm has a market capitalization of $18.01 billion, a price-to-earnings ratio of 39.94, a PEG ratio of 2.62 and a beta of 0.45. The firm has a 50 day moving average price of $151.34 and a 200-day moving average price of $159.00. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the business earned $2.16 earnings per share. Equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.34%. Clorox’s dividend payout ratio is currently 133.33%.

Analyst Ratings Changes

A number of equities research analysts recently commented on CLX shares. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Barclays reduced their price objective on shares of Clorox from $140.00 to $139.00 and set an “underweight” rating on the stock in a research report on Thursday. DA Davidson dropped their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Wells Fargo & Company boosted their price target on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 4th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $159.50.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.